Latham-Led Biopharma Co. Gets $15M For COVID-19 Vaccine
A Latham & Watkins LLP-advised Chinese biopharmaceutical company raised $15 million to continue its research on a vaccine for the coronavirus....To view the full article, register now.
Already a subscriber? Click here to view full article